EMBL-EBI | Chemical Biology Resources | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:85995 - lenvatinib mesylate

Default Structure
ChEBI IDCHEBI:85995
ChEBI Namelenvatinib mesylate
Stars
DefinitionA methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine.
Last Modified20 May 2017
SubmitterSteve
DownloadsMolfile
FormulaC21H19ClN4O4.CH4O3S
Net Charge0
Average Mass522.967
Monoisotopic Mass522.09760
SMILESCOc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O
InChIInChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2,3)4/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28);1H3,(H,2,3,4)
InChIKeyHWLFIUUAYLEFCT-UHFFFAOYSA-N
Roles Classification
Biological Roles:
fibroblast growth factor receptor antagonist  An antagonist at the fibroblast growth factor receptor.
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor  An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
vascular endothelial growth factor receptor antagonist  An antagonist at the vascular endothelial growth factor receptor.
Applications:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
orphan drug  Any drug that has been developed specifically for treatment of a rare medical condition, the condition itself being known as an orphan disease.
ChEBI Ontology
Outgoing Relation(s)
lenvatinib mesylate (CHEBI:85995) has part lenvatinib(1+) (CHEBI:85998)
lenvatinib mesylate (CHEBI:85995) has role antineoplastic agent (CHEBI:35610)
lenvatinib mesylate (CHEBI:85995) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434)
lenvatinib mesylate (CHEBI:85995) has role fibroblast growth factor receptor antagonist (CHEBI:63457)
lenvatinib mesylate (CHEBI:85995) has role orphan drug (CHEBI:71031)
lenvatinib mesylate (CHEBI:85995) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207)
lenvatinib mesylate (CHEBI:85995) is a methanesulfonate salt (CHEBI:38037)
IUPAC Names 
6-carbamoyl-4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinolin-1-ium methanesulfonate
methanesulfonic acid—4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide (1/1)
Synonyms  Source
E7080ChemIDplus
E-7080 MESYLATEChEMBL
E7080 MESYLATEChEMBL
Lenvatinib mesilateKEGG DRUG
Lenvatinib methanesulfonateChEMBL
N-(4-((6-Carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)-N'-cyclopropylurea monomethanesulfonateChemIDplus
Brand Names  Source
LenvimaKEGG DRUG
LenvimaChEBI
Manual XrefsDatabases
D09920KEGG DRUG
Registry NumbersSources
Reaxys:14616854Reaxys
CAS:857890-39-2ChemIDplus
CAS:857890-39-2KEGG DRUG
Citations